Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer.
Clinical oncology (Royal College of Radiologists (Great Britain)) • Vol. 21, Issue 6 • 2009
Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.
British journal of haematology • Vol. 145, Issue 6 • 2009
Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety.
Journal of medicinal chemistry • Vol. 51, Issue 19 • 2008
HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat.
Biochemical and biophysical research communications • Vol. 370, Issue 1 • 2008
